2007
DOI: 10.1016/j.burns.2006.10.381
|View full text |Cite
|
Sign up to set email alerts
|

Rosiglitazone, a PPAR-γ ligand, protects against burn-induced oxidative injury of remote organs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
26
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(29 citation statements)
references
References 38 publications
3
26
0
Order By: Relevance
“…The protective effect was associated with downregulation of the local expression of several potent proinflammatory cytokines, chemokine adhesion molecules, and neutrophil accumulation (2). PPAR␥ ligands have also inhibitory effects on generation of reactive oxygen species and lipid peroxidation in the liver (28,32). Consistent with these previous findings, in the present study we have demonstrated that ciglitazone reduced liver neutrophil infiltration in both age groups.…”
Section: Discussionsupporting
confidence: 92%
“…The protective effect was associated with downregulation of the local expression of several potent proinflammatory cytokines, chemokine adhesion molecules, and neutrophil accumulation (2). PPAR␥ ligands have also inhibitory effects on generation of reactive oxygen species and lipid peroxidation in the liver (28,32). Consistent with these previous findings, in the present study we have demonstrated that ciglitazone reduced liver neutrophil infiltration in both age groups.…”
Section: Discussionsupporting
confidence: 92%
“…Evidence from animal and human studies suggested that there is a correlation between the tissue MDA levels and the degree of burn complications, including shock and remote organ damage (32)(33)(34)(35). In the present study, burn-induced increase in the lung MDA levels were prevented by etanercept treatment, suggesting that antagonism of TNF- exerts a potent protective effect against lipid peroxidation.…”
Section: Discussionsupporting
confidence: 59%
“…Indeed, recent clinical studies indicated that PGC-1α agonists can alleviate post-burn insulin resistance (34,35) and prevent burn-induced damage in remote organs (36). That PGC-1ß is a highly inducible factor in most tissues and responds to common pathways of calcium and cAMP signaling strongly suggests that it may be possible to find drugs that induce PGC-1ß.…”
Section: Discussionmentioning
confidence: 99%